Sort
23,748 grants matching “melanoma”
Targeting RET in Lung Cancer
$541,784Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Targeting RET in Lung Cancer
$541,784Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Targeting RET in Lung Cancer
$541,784Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Targeting RET in Lung Cancer
$541,784Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2017 · CA
INTEGRATION OF CLINICAL, MOLECULAR, AND IMMUNE FEATURES TO IMPROVE RISK STRATIFICATION AND OUTCOMES IN MELANOMA PATIENTS WITH SENTINEL LYMPH NODE MET
$541,779The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2018 · Defense Health Agency
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$541,453Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$541,453Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
$541,408Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2019 · CA
Dissecting single cell dynamics that coordinate neural crest migration and diversification
$541,385Thomas F Schilling · University Of California-Irvine · R01 · FY2024 · DE
Targeting Tumors with NF1 Loss
$541,146Yolanda Sanchez · Dartmouth College · R01 · FY2018 · NS
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers
$540,823Efstathios Karathanasis · Case Western Reserve University · R01 · FY2025 · CA
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
$540,797Grace Elizabeth Pluhar · University Of Minnesota · U01 · FY2021 · CA
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
$540,797Grace Elizabeth Pluhar · University Of Minnesota · U01 · FY2020 · CA
DEVELOPMENTAL FUNDS (Core 002)
$540,774Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · CA
Proj. 1 Targeting Tumor-Specific Neoepitopes for Glioblastoma Immunotherapy
$540,614David Reardon · Brigham And Women'S Hospital · P01 · FY2021 · CA
Background free amplified single-molecule FISH for in situ and flow cytometric applications
$540,608Sanjay Tyagi · Rbhs-New Jersey Medical School · R01 · FY2019 · CA
Tumor-specific T cell state dynamics and heterogeneity in early tumorigenesis
$540,596Andrea Schietinger · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA
Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers
$540,527Robert J. Canter · University Of California At Davis · U01 · FY2020 · CA
Defining the role of NF1 and SPRED1 loss in melanoma
$540,515Iwei Yeh · University Of California, San Francisco · R37 · FY2022 · CA
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
$540,493Eric T Ahrens · University Of California, San Diego · R01 · FY2017 · CA
RADIORECEPTOR GUIDED SURGERY OF NEURAL CREST TUMORS
$540,467University Of Iowa · R01 · FY2003 · EB
Flow Cytometry
$540,453Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P30 · FY2011 · CA
Preserving CTLA-4 immune checkpoint for safer and more effective cancer immunotherapy
$540,369Lishan Su · University Of Maryland Baltimore · R01 · FY2020 · AI
UVL, ROS, PIGMENTATION, GENETIC PREDISPOSITION, AND EPIGENETIC GENE SILENCING IN MELANOMA
$540,359Yale Univ · · FY2010 · Department of Defense
Optimization of a personalized skin cancer risk intervention for at-risk young adults
$540,247Yelena Ping Wu · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA